These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 23789923)

  • 1. Proteins: emerging carrier for delivery of cancer therapeutics.
    Yewale C; Baradia D; Vhora I; Misra A
    Expert Opin Drug Deliv; 2013 Oct; 10(10):1429-48. PubMed ID: 23789923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodegradable polymers for targeted delivery of anti-cancer drugs.
    Doppalapudi S; Jain A; Domb AJ; Khan W
    Expert Opin Drug Deliv; 2016 Jun; 13(6):891-909. PubMed ID: 26983898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organic nanoparticle systems for spatiotemporal control of multimodal chemotherapy.
    Meng F; Han N; Yeo Y
    Expert Opin Drug Deliv; 2017 Mar; 14(3):427-446. PubMed ID: 27476442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cationic nanoparticles for cancer therapy.
    Bilensoy E
    Expert Opin Drug Deliv; 2010 Jul; 7(7):795-809. PubMed ID: 20446858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The achievement of ligand-functionalized organic/polymeric nanoparticles for treating multidrug resistant cancer.
    Lee WH; Loo CY; Leong CR; Young PM; Traini D; Rohanizadeh R
    Expert Opin Drug Deliv; 2017 Aug; 14(8):937-957. PubMed ID: 27759437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances on biocompatible and biodegradable nanoparticles as gene carriers.
    Mokhtarzadeh A; Alibakhshi A; Yaghoobi H; Hashemi M; Hejazi M; Ramezani M
    Expert Opin Biol Ther; 2016 Jun; 16(6):771-85. PubMed ID: 26998622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biopolymeric alginate-chitosan nanoparticles as drug delivery carriers for cancer therapy.
    Bhunchu S; Rojsitthisak P
    Pharmazie; 2014 Aug; 69(8):563-70. PubMed ID: 25158565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
    Varshosaz J; Farzan M
    World J Gastroenterol; 2015 Nov; 21(42):12022-41. PubMed ID: 26576089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug Delivery Vehicles Based on Albumin-Polymer Conjugates.
    Jiang Y; Stenzel M
    Macromol Biosci; 2016 Jun; 16(6):791-802. PubMed ID: 26947019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient delivery of therapeutic agents by using targeted albumin nanoparticles.
    Kouchakzadeh H; Safavi MS; Shojaosadati SA
    Adv Protein Chem Struct Biol; 2015; 98():121-43. PubMed ID: 25819278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbon nanotubes for delivery of small molecule drugs.
    Wong BS; Yoong SL; Jagusiak A; Panczyk T; Ho HK; Ang WH; Pastorin G
    Adv Drug Deliv Rev; 2013 Dec; 65(15):1964-2015. PubMed ID: 23954402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current knowledge on biodegradable microspheres in drug delivery.
    Prajapati VD; Jani GK; Kapadia JR
    Expert Opin Drug Deliv; 2015 Aug; 12(8):1283-99. PubMed ID: 25687105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classification of stimuli-responsive polymers as anticancer drug delivery systems.
    Taghizadeh B; Taranejoo S; Monemian SA; Salehi Moghaddam Z; Daliri K; Derakhshankhah H; Derakhshani Z
    Drug Deliv; 2015 Feb; 22(2):145-55. PubMed ID: 24547737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the role of polymeric conjugates toward anti-cancer drug delivery: Current trends and future projections.
    Khan J; Alexander A; Ajazuddin ; Saraf S; Saraf S
    Int J Pharm; 2018 Sep; 548(1):500-514. PubMed ID: 29964172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation and physiologic factors affecting the pharmacology of carrier-mediated anticancer agents.
    Lucas AT; Madden AJ; Zamboni WC
    Expert Opin Drug Metab Toxicol; 2015; 11(9):1419-33. PubMed ID: 26173794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PLGA Nanoparticles and Their Versatile Role in Anticancer Drug Delivery.
    Khan I; Gothwal A; Sharma AK; Kesharwani P; Gupta L; Iyer AK; Gupta U
    Crit Rev Ther Drug Carrier Syst; 2016; 33(2):159-93. PubMed ID: 27651101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of protein- and Peptide-based nanoparticles as potential vehicles for anticancer drugs.
    Elzoghby AO; Elgohary MM; Kamel NM
    Adv Protein Chem Struct Biol; 2015; 98():169-221. PubMed ID: 25819280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Prominent Role of Protein-Based Delivery Systems on the Development of Cancer Treatment.
    Kouchakzadeh H; Abbas Shojaosadati S
    Curr Pharm Des; 2016; 22(22):3455-65. PubMed ID: 26845324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-assembled non-covalent protein-drug nanoparticles: an emerging delivery platform for anti-cancer drugs.
    Hassanin IA; Elzoghby AO
    Expert Opin Drug Deliv; 2020 Oct; 17(10):1437-1458. PubMed ID: 32820954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.